TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/21 16:41 | 9/17/21 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Witter Malcolm G | OH | D | P | 32 | 1.60 | 0 | 20 | 26 | 98 | D | |||||||||||||||
7/26/21 16:38 | 7/26/21 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Witter Malcolm G | OH | D | P | 25 | 1.70 | 0 | 15 | 24 | 78 | D | |||||||||||||||
4/26/21 17:14 | 4/23/21 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Witter Malcolm G | OH | D | P | 16 | 1.60 | 0 | 10 | 21 | 57 | D | |||||||||||||||
3/29/21 16:38 | 3/29/21 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Witter Malcolm G | OH | D | P | 45 | 2.07 | 0 | 22 | 84 | 47 | D | |||||||||||||||
3/3/21 16:34 | 3/3/21 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Witter Malcolm G | OH | D | P | 35 | 2.31 | 0 | 15 | 143 | 26 | D | |||||||||||||||
12/30/20 16:33 | 12/28/20 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Witter Malcolm G | OH | D | P | 10 | 2.07 | 0 | 5 | 91 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |